Home  >  Products  >  NFATC1 (nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1) Blocking Peptide (the C terminal of NFATC1)(100ug)
NFATC1 (nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1) Blocking Peptide (the C terminal of NFATC1)(100ug)

NFATC1 (nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1) Blocking Peptide (the C terminal of NFATC1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NFATC1 Antibody(ARP39978_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP39978
Size: 100ug
Weight: 100kDa
Gene: 4772
Format: Lyophilized powder
Target: NFATC1 is a component of the nuclear factor of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation, and an inducible nuclear component. Proteins belonging to this family of transcription factors play a central role in inducible gene transcription during immune response. The product of this gene is an inducible nuclear component. It functions as a major molecular target for the immunosuppressive drugs such as cyclosporin A. Different isoforms of this protein may regulate inducible expression of different cytokine genes.
Alternative names: MGC138448; NF-ATC; NFAT2; NFATc
See Full Product Listings >